Facial Paralysis: Is This Stroke, Botox, or Bell’s Palsy? The Curbsiders share what they’ve learned from an expert neurologist on the evaluation and management of Bell’s palsy.

No writing assistance was utilized in the production of this manuscript. The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of ...

“We've never figured out what the anticoagulation or antiplatelet regimens should be in our TAVR patients, and this might be a really good way,” she added. Mehran reiterated that the higher incidence ...

Dual antiplatelet therapy (DAPT), comprising aspirin plus a P2Y12 inhibitor, is already recommended for people with ACS. While it reduces the risk of recurrent MI, it can increase bleeding risk in ...

As in PRESTIGE-AF, some patients get no antithrombotic therapy, while the rest get a mix of aspirin, other antiplatelets, or left atrial appendage occlusion (LAAO). In that landscape, “this trial was ...

use of antiplatelet agents, anticoagulants or statin drugs during the acute period, steno‐occlusion of the intra‐ or extracranial artery relevant to the acute ischemic lesions, and mean systolic blood ...

Bleeding after starting anticoagulation for atrial fibrillation (AF) may be the first sign of malignancy, especially in elderly individuals. There are no recommendations to guide investigations for ...

Although aspirin is routinely recommended for patients with CABG, the optimal antiplatelet regimen after CABG remains unclear. We evaluated the efficacies and risks of different antiplatelet regimens ...

The optimal threshold for defining prognostically relevant periprocedural myocardial injury (PMI) in patients with NSTEMI was found to be a post-PCI change in cardiac troponin I (cTnI) of >40%, along ...

In CKD+HF, CKD+T2D and HF+T2D groups, prescription rates of renin-angiotensin system inhibitors (71%, 64.1% and 74.4%), beta-blockers (53.1%,36.2% and 55.1%), antiplatelets (56.2%, 45.2% and 54.4%) ...